Clinical Trial Update: Gliadel Wafer and Fluorescence-Guided Surgery With 5-ALA Followed by Radiation Therapy And Temozolomide in Treating Patients With Primary Glioblastoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Gliadel Wafer with fluorescence-guided surgery using 5-ALA followed by radiation therapy and temozolomide in patients with primary glio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• 5-ALA (5-aminolevulinic acid) (5-aminolevulinic acid)
• GLIADEL wafer (carmustine)
• Radiation therapy
• Temozolomide (Temozolomide)

Snippet

Sponsor: University College, London | Conditions: Glioblastoma | Phase 2 | Status: COMPLETED | Results posted: 2017-08-14